Skip to main content

Table 1 Distribution of gender, sample, ward, sccmec, spa types and pattern of antibiotics in MRSA isolates

From: Characterization of SCCmec, spa types and Multi Drug Resistant of methicillin-resistant Staphylococcus aureus isolates among inpatients and outpatients in a referral hospital in Shiraz, Iran

Number strain

Gender

Hospital

Sample

Ward

Spa typing

Sccmec type

Pattern resistance of antibiotics

1

F

Faghihi

Skin

Dermatology

t030

I

P, E, AZT, CC, FM

4

M

Faghihi

Skin

Dermatology

t021

III

P, CIP, E, AZT, SXT, GM, NOR, CEF

6

M

Faghihi

Nasal

OUT

t030

IIIA

SXT

9

F

Faghihi

Fluid

Internal

t030

I

P, CIP, AZT, SXT, CC, GM, NOR, CEF

12

F

Faghihi

Nasal

OUT

t386

IIIA

P, CIP, E, AZT, SXT, CC, GM, NOR, CEF

16

M

Faghihi

Wound

Dermatology

t314

II

P, CIP, GM, FM

23

F

Faghihi

Skin

OUT

t386

IV

P, CIP, E, AZT, SXT

27

F

Nemazee

Blood

Emergency

t030

–

P, GM

33

M

Faghihi

Wound

Internal

t030

IV

P

38

F

Faghihi

Skin

Dermatology

t021

III

CIP, SXT, NOR

39

F

Faghihi

Skin

Dermatology

t030

II

P, CIP, E, AZT, CC, GM, NOR, CEF

40

F

Faghihi

Blood

Internal

t 386

–

P, CIP, E, AZT, NOR, CEF

41

F

Faghihi

Skin

Dermatology

t021

IA

CIP, E, AZT, CC, NOR, FM

43

M

Faghihi

Skin

Dermatology

t037

III

P, CIP, E, AZT, SXT, CC, NOR, FM, RP, CEF

44

M

Faghihi

Sputum

ICU

t021

I

SXT

46

M

Faghihi

Skin

Dermatology

t 186

IV

P, E, AZT

48

F

Faghihi

Skin

OUT

t1877

III

P

49

F

Faghihi

Skin

Dermatology

t314

IV

P, E, AZT, CC, NOR

50

F

Faghihi

Skin

Dermatology

t021

IV

P, E, AZT

65

F

Faghihi

Skin

Dermatology

t345

I

P, CIP, E, AZT, SXT, CC, GM, NOR, CEF

70

M

Faghihi

Skin

Dermatology

t 1877

III

P, CIP, E, AZT, SXT, CC, GM, NOR, CEF

73

F

Faghihi

Skin

OUT

t1877

IV

P, E, AZT, SXT, CC, NOR, CEF

75

M

Faghihi

Skin

Dermatology

t790

IV

P

79

M

Faghihi

Blood

Internal

t1877

III

P, CIP, E, AZT, SXT, CC, NOR, CEF

92

M

Faghihi

Wound

Dermatology

t037

IA

P, CIP, E, AZT, CC, NOR

96

F

Faghihi

Wound

OUT

t790

IV

P, E, AZT, CC, CEF

97

M

Nemazee

Skin

OUT

t386

II

P, E, AZT, CEF

99

F

Nemazee

Blood

Internal

t386

–

P, E, AZT, CEF

100

M

Nemazee

Blood

Emergency

t030

III

P, CIP, E, AZT, CC, GM, NOR, FM, RP, CEF

103

M

Nemazee

Blood

Emergency

t030

III

P, CIP, E, AZT, CC, GM, NOR, RP, CEF

106

F

Faghihi

Nasal

OUT

t1877

–

P

108

F

Nemazee

Abses

Emergency

t021

III

P, CIP, E, AZT, SXT, NOR

109

M

Nemazee

Blood

Emergency

t325

IV

P

110

F

Nemazee

Blood

OUT

t325

IV

P, CEF

117

M

Faghihi

Skin

Dermatology

t021

IV

P, CIP, E, AZT, SXT, NOR

118

F

Faghihi

Skin

Dermatology

t037

IIIA

P, CIP, E, AZT, SXT, GM, NOR, CEF

121

F

Nemazee

Blood

Emergency

t030

II

P

122

F

Nemazee

Wound

OUT

t1816

IV

P, E, AZT, CEF

124

M

Nemazee

eye

ICU

t304

III

P, CEF

125

M

Faghihi

Wound

Internal

t021

III

P, CIP, SXT, NOR

126

M

Faghihi

Wound

Internal

t021

III

P, CIP, SXT, NOR

127

M

Faghihi

Skin

Dermatology

t003

II

PEN

128

F

Nemazee

Sputum

ICU

t1877

IV

P, E, AZT

150

M

Nemazee

Sputum

ICU

t021

III

P, E, AZT

151

M

Nemazee

Sputum

ICU

t030

IIIA

P, CIP, E, AZT, SXT, CC, NOR, CEF

154

F

Nemazee

Sputum

ICU

t037

III

P, CIP, E, AZT, CC, GM, NOR, CEF

155

M

Nemazee

Wound

OUT

t018

–

P, CIP, E, AZT, CC, , GM, NOR, CEF

156

F

Nemazee

Nasal

Emergency

t081

III

P

157

F

Nemazee

Blood

Internal

t030

II

P, CIP, E, AZT, SXT, CC, GM, FM, RP, CEF

159

M

Nemazee

Nasal

OUT

t030

III

P, CIP, E, AZT, CC, GM, NOR, CEF

  1. F female, M male, OUT outpatient, P penicillin, C chloramphenicol, CIP ciprofloxacin, E erythromycin, AZT azithromycin, SXT trimethoprim–sulfamethoxazole, CC clindamycin, GM gentamicin, NOR norfloxacin, FM nitrofurantoin, RP rifampicin, CEF ceftaroline